| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 核素药物(元) | 503,357,613.41 | 1,012,066,389.09 | 499,471,173.31 |
| 原料药相关产品(元) | 611,040,395.44 | 1,255,393,593.67 | 657,180,371.15 |
| 制剂产品(元) | 182,207,723.64 | 325,491,662.12 | 179,065,066.84 |
| 其他产品(元) | 87,106,150.37 | 275,984,892.84 | 84,994,763.87 |
| 营业成本(元) | |||
| 核素药物(元) | 164,765,838.43 | 312,964,145.35 | 135,111,890.45 |
| 原料药相关产品(元) | 379,453,727.54 | 875,058,335.28 | 482,407,339.55 |
| 制剂产品(元) | 110,046,070.02 | 196,168,248.15 | 110,307,302.49 |
| 其他产品(元) | 85,218,882.20 | 132,337,959.51 | 58,642,734.46 |
| 毛利(元) | |||
| 核素药物(元) | 338,591,774.98 | 699,102,243.74 | 364,359,282.86 |
| 原料药相关产品(元) | 231,586,667.90 | 380,335,258.39 | 174,773,031.60 |
| 制剂产品(元) | 72,161,653.62 | 129,323,413.97 | 68,757,764.35 |
| 其他产品(元) | 1,887,268.17 | 143,646,933.33 | 26,352,029.41 |
| 毛利率(%) | |||
| 核素药物(%) | 67.27 | 69.08 | 72.95 |
| 原料药相关产品(%) | 37.90 | 30.30 | 26.59 |
| 制剂产品(%) | 39.60 | 39.73 | 38.40 |
| 其他产品(%) | 2.17 | 52.05 | 31.00 |
| 收入构成(%) | |||
| 核素药物(%) | 36.38 | 35.28 | 35.16 |
| 原料药相关产品(%) | 44.16 | 43.76 | 46.26 |
| 制剂产品(%) | 13.17 | 11.35 | 12.60 |
| 其他产品(%) | 6.30 | 9.62 | 5.98 |
| 毛利构成(%) | |||
| 核素药物(%) | 52.56 | 51.69 | 57.45 |
| 原料药相关产品(%) | 35.95 | 28.12 | 27.56 |
| 制剂产品(%) | 11.20 | 9.56 | 10.84 |
| 其他产品(%) | 0.29 | 10.62 | 4.15 |